Natural Products and some Semi-synthetic Analogues as Potential TRPV1 Ligands for Attenuating Neuropathic Pain

被引:21
作者
Naik, Gaurav Gopal [1 ]
Uniyal, Ankit [1 ]
Chouhan, Deepak [1 ]
Tiwari, Vinod [1 ]
Sahu, Alakh N. [1 ]
机构
[1] Indian Inst Technol BHU Varanasi, Dept Pharmaceut Engn & Technol, Varanasi, Uttar Pradesh, India
关键词
TRPV1; channels; neuropathic pain; natural products; semi-synthetic analogues; agonists; antagonists; ROOT GANGLION NEURONS; ION-CHANNEL; VANILLOID; RAT MODEL; ALLYL ISOTHIOCYANATE; CAPSAICIN RECEPTOR; PUNGENT COMPOUNDS; PANAX-GINSENG; BLACK PEPPER; ACTIVATION;
D O I
10.2174/1389201022666210719155931
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Natural products and leads inspired by them have acted as a probe for successful drug discovery for many decades. Pain is an obnoxious sensory and emotional experience associated with potential tissue damage. It affects the quality of life of patients to a greater extent. Despite the availability of several agents targeting TRP receptors, none of them can proficiently alleviate neuropathic pain. TRPV1 is a prospective target for treating neuropathic pain as it is recognized to modulate the pain circuitry at the periphery and the central level. In this review, we have discussed several natural molecules, such as Capsaicinoids, Capsinoids, Piperine, Eugenol, Scutigeral, Ginsenosides, Cinnamaldehyde, Camphor, Shogaol, Gingerols, Zingerone, Allicin, Evodiamine, Allylisothiocyanate, Cannabidiol, Ricinoleic acid, Isovelleral, Capsazepine, Thapsigargin, Pellitorine, Yohimbine, Curcumin and some semi-synthetic analogues that activate TRPV1 channels and consequently, can be further harnessed for the treatment of neuropathic pain.
引用
收藏
页码:766 / 786
页数:21
相关论文
共 151 条
  • [131] Neuropathic pain in the general population: A systematic review of epidemiological studies
    van Hecke, O.
    Austin, Sophie K.
    Khan, Rafi A.
    Smith, B. H.
    Torrance, N.
    [J]. PAIN, 2014, 155 (04) : 654 - 662
  • [132] Vandebroek I., 2020, POPULAR MED PLANTS P, P187, DOI [10.1007/978-3-030-48927-4_21, DOI 10.1007/978-3-030-48927-4_21]
  • [133] Vriens J, 2008, CURR NEUROPHARMACOL, V6, P79, DOI 10.2174/157015908783769644
  • [134] Pain pathways and potential new targets for pain relief
    Wang, Menglan
    Thyagarajan, Baskaran
    [J]. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2022, 69 (01) : 110 - 123
  • [135] High affinity antagonists of the vanilloid receptor
    Wang, Y
    Szabo, T
    Welter, JD
    Toth, A
    Tran, R
    Lee, JY
    Kang, SU
    Suh, YG
    Blumberg, PM
    Lee, J
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (04) : 947 - 956
  • [136] Site-specific contacts enable distinct modes of TRPV1 regulation by the potassium channel Kvβ1 subunit
    Wang, Yuanyuan
    Mo, Xiaoyi
    Ping, Conghui
    Huang, Qian
    Zhang, Hao
    Xie, Chang
    Zhong, Bo
    Li, Dongdong
    Yao, Jing
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (50) : 17337 - 17348
  • [137] Human pharmacological approaches to TRP-ion-channel-based analgesic drug development
    Weyer-Menkhoff, Iris
    Loetsch, Joern
    [J]. DRUG DISCOVERY TODAY, 2018, 23 (12) : 2003 - 2012
  • [138] Developing piperine towards TRPV1 and GABAA receptor ligands - synthesis of piperine analogs via Heck-coupling of conjugated dienes
    Wimmer, Laurin
    Schoenbauer, David
    Pakfeifer, Peter
    Schoeffmann, Angela
    Khom, Sophia
    Hering, Steffen
    Mihovilovic, Marko D.
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2015, 13 (04) : 990 - 994
  • [139] Evodiamine ameliorates paclitaxel-induced neuropathic pain by inhibiting inflammation and maintaining mitochondrial anti-oxidant functions
    Wu, Peipei
    Chen, Yong
    [J]. HUMAN CELL, 2019, 32 (03) : 251 - 259
  • [140] The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities
    Xu, Dixon H.
    Cullen, Benjamin D.
    Tang, Meng
    Fang, Yujiang
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2020, 21 (05) : 390 - 402